ACUTA CAPITAL PARTNERS, LLC Portfolio

Auto-discovered active 13F filer.

SEC 13F CIK: 0001582844

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallHealth TiltHigh Turnover how tags are computed

Q3 2023 · 43 positions · Total reported value $137.54M · Top-10 concentration 57.7% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 52.9% · 11 new · 7 cut · 0 exited

Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -16.4% · vs SPY -18.5% · Prev Value $143.49M — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -8.3% · vs SPY -10.5% · Latest Value $126.75M — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q3 2023 13F filing, ACUTA CAPITAL PARTNERS, LLC disclosed 43 equity positions with a combined reported value of $137.54M. The filing implies a moderately concentrated portfolio: its ten largest positions account for 57.7% of reported value. HoldingsHub classifies the profile as Small / Health Tilt / High Turnover.

The largest disclosed positions as of Q3 2023 were TSHA ($12.10M), APLS ($9.30M), WHWK ($8.95M). By sector, the heaviest allocations are Health Care 64.4%, Industrials 1.7%.

Versus the prior quarter, ACUTA CAPITAL PARTNERS, LLC opened 11 new positions, trimmed 7 and fully exited 0, a turnover rate of 52.9% of positions.

The largest new positions opened in Q3 2023 were TSHA ($12.10M), APLS ($9.30M), WHWK ($8.95M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q3 2023)

  • TSHA TAYSHA GENE THERAPIES INC · $12.10M
  • APLS APELLIS PH · $9.30M
  • WHWK WHITEHAWK THERAPEUTICS INC · $8.95M
  • PRAX PRAXIS PRECISION MEDICINES I · $7.67M
  • RYZB RAYZEBIO INC · $7.65M
  • RCKT ROCKET PHARMACEUTICALS INC · $7.42M
  • VTYX VENTYX BIOSCIENCES INC · $7.13M
  • IRON DISC MEDICINE INC · $6.49M

Fully Exited (vs previous quarter)

No tracked position was fully exited this quarter.

Insider Transactions (Form 4)

Latest ACUTA CAPITAL PARTNERS, LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Acuta Capital Partners, based in Redwood City, CA, United States, files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 23 positions worth $143.49M in total. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: REDWOOD CITY, CA, United States
  • SEC registration: 801-136966 (status: Approved), registered 2026-09-09
  • Regulatory AUM (Form ADV): $172.53M as of 2026-06-30
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 2 private funds, of which 2 hedge funds
  • Website: acutacapital.com

Portfolio Structure

  • 23 positions · $143.49M reported value (Q2 2026)
  • Top 10 holdings = 73.7% of reported value
  • Largest position: PRAX (PRAXIS PRECISION MEDICINES I) at 19.3%
  • Average position size: $6.24M

Sector Tilt

  • Health Care 100.0%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q2 2026: 4 new, 7 added, 6 reduced, 7 exited
  • 6 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 64.4%
Other 33.9%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 3.83M $12.10M 8.79%
8.79%
New
2 244.48K $9.30M 6.76%
6.76%
New
3 1.85M $8.95M 6.51%
6.51%
New
4 4.49M $7.67M 5.58%
5.58%
New
5 344.57K $7.65M 5.56%
5.56%
New
6 362.00K $7.42M 5.39%
5.39%
New
7 205.38K $7.13M 5.19%
5.19%
New
8 138.20K $6.49M 4.72%
4.72%
New
9 702.09K $6.40M 4.66%
4.66%
New
10 418.00K $6.23M 4.53%
4.53%
New
11 121.02K $6.17M 4.49%
4.49%
New
12 129.00K $4.95M 3.60%
3.60%
New
13 297.04K $4.31M 3.14%
3.14%
New
14 270.32K $3.64M 2.64%
2.64%
New
15 126.50K $3.54M 2.58%
2.58%
New
16 224.34K $3.44M 2.50%
2.50%
New
17 122.34K $3.37M 2.45%
2.45%
New
18 94.00K $2.80M 2.03%
2.03%
New
19 555.26K $2.79M 2.03%
2.03%
New
20 300.13K $2.40M 1.74%
1.74%
New
21 551.01K $2.39M 1.74%
1.74%
New
22 323.35K $2.09M 1.52%
1.52%
New
23 153.01K $1.89M 1.37%
1.37%
New
24 15.50K $1.88M 1.37%
1.37%
New
25 230.00K $1.87M 1.36%
1.36%
New
26 1.00K $1.77M 1.28%
1.28%
New
27 103.60K $1.42M 1.03%
1.03%
New
28 146.50K $1.31M 0.95%
0.95%
New
29 718.74K $934.36K 0.68%
0.68%
New
30 121.69K $833.59K 0.61%
0.61%
New
31 2.50K $825.00K 0.60%
0.60%
New
32 39.94K $549.51K 0.40%
0.40%
New
33 11.30K $512.57K 0.37%
0.37%
New
34 32.80K $506.43K 0.37%
0.37%
New
35 354.17K $488.75K 0.35%
0.35%
New
36 310.00K $409.20K 0.30%
0.30%
New
37 121.30K $320.23K 0.23%
0.23%
New
38 5.00K $252.10K 0.18%
0.18%
New
39 13.30K $213.86K 0.15%
0.15%
New
40 19.50K $156.97K 0.11%
0.11%
New
41 99.61K $126.50K 0.09%
0.09%
New
42 27.50K $41.25K 0.03%
0.03%
New
43 90.83K $9.08K 0.01%
0.01%
New

FAQ

What did ACUTA CAPITAL PARTNERS, LLC buy in 2023-Q3?

In its 2023-Q3 13F filing, ACUTA CAPITAL PARTNERS, LLC reported 43 equity positions worth $137.54M in aggregate; its largest disclosed positions were TSHA ($12.10M), APLS ($9.30M), WHWK ($8.95M).

How large is ACUTA CAPITAL PARTNERS, LLC's portfolio?

ACUTA CAPITAL PARTNERS, LLC reported $137.54M of long equity holdings across 43 positions as of 2023-Q3. Top-10 holdings account for 57.7% of reported value.

What is ACUTA CAPITAL PARTNERS, LLC's investment style?

HoldingsHub classifies the portfolio as Small / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/acuta-capital-partners/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →